Drug intelligence / Profile preview

MucoShield

Development stage
Preclinical
Lead developer
Prime Vector Technologies
Modality
Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Intranasal
01

Overview

MucoShield is a preclinical-stage intranasal vaccine developed by Prime Vector Technologies for the prevention of Human Metapneumovirus (HMPV) infection. It utilizes a multivalent antigen design delivered via an Orf virus (ORFV) viral vector platform. The vaccine is specifically designed to activate mucosal immunity at the site of entry, providing a localized defense against HMPV, which is a significant cause of upper and lower respiratory tract infections in children, the elderly, and immunocompromised individuals. By utilizing the ORFV vector, MucoShield aims to induce both robust mucosal and systemic immune responses without the need for traditional adjuvants.

Brand names
MucoShield
02

Targets

HMPV F (Human metapneumovirus fusion protein)

Beyond the preview

Go deeper on MucoShield.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MucoShield.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call